Does LETROZOLE Cause Tumour marker increased? 343 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 343 reports of Tumour marker increased have been filed in association with LETROZOLE (Letrozole). This represents 1.1% of all adverse event reports for LETROZOLE.
343
Reports of Tumour marker increased with LETROZOLE
1.1%
of all LETROZOLE reports
28
Deaths
31
Hospitalizations
How Dangerous Is Tumour marker increased From LETROZOLE?
Of the 343 reports, 28 (8.2%) resulted in death, 31 (9.0%) required hospitalization, and 13 (3.8%) were considered life-threatening.
Is Tumour marker increased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LETROZOLE. However, 343 reports have been filed with the FAERS database.
What Other Side Effects Does LETROZOLE Cause?
Neutropenia (3,683)
Fatigue (3,568)
Malignant neoplasm progression (3,445)
Nausea (2,894)
Arthralgia (2,318)
Diarrhoea (2,282)
Metastases to bone (1,735)
Dyspnoea (1,621)
Asthenia (1,589)
Vomiting (1,560)
What Other Drugs Cause Tumour marker increased?
PALBOCICLIB (817)
FULVESTRANT (408)
NIRAPARIB (356)
RIBOCICLIB (317)
RUCAPARIB CAMSYLATE (257)
CAPECITABINE (228)
EVEROLIMUS (228)
ELACESTRANT (222)
OLAPARIB (171)
ANASTROZOLE (142)
Which LETROZOLE Alternatives Have Lower Tumour marker increased Risk?
LETROZOLE vs LETROZOLE\RIBOCICLIB
LETROZOLE vs LEUCOVORIN
LETROZOLE vs LEUCOVORIN\LEUCOVORIN
LETROZOLE vs LEUPROLIDE
LETROZOLE vs LEVALBUTEROL